Home / Brands / Amerigen Pharmaceuticals
Amerigen Pharmaceuticals Recalls
4 recalls on record · October 24, 2018 to February 27, 2019 · Drugs
Recalls by year
18
19
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
February 27, 2019DrugsFDA
Amerigen Pharmaceuticals Inc. recalls Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx
Hazard: Failed dissolution specifications
January 2, 2019DrugsFDA
Amerigen Pharmaceuticals Inc. recalls Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, C
Hazard: Failed Dissolution Specifications
January 2, 2019DrugsFDA
Amerigen Pharmaceuticals Inc. recalls Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC 43975-253-14) bottles, Rx
Hazard: Failed Dissolution Specifications
October 24, 2018DrugsFDA
Amerigen Pharmaceuticals Inc. recalls Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx
Hazard: Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.